GPI-defective monocytes from paroxysmal nocturnal hemoglobinuria patients show impaired in vitro dendritic cell differentiation

J Leukoc Biol. 2004 Sep;76(3):634-40. doi: 10.1189/jlb.1203607. Epub 2004 Jun 14.

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal, acquired hematopoietic disorder characterized by a phosphatidylinositol (PI) glycan-A gene mutation, which impairs the synthesis of the glycosyl-PI (GPI) anchor, thus causing the absence of all GPI-linked proteins on the membrane of the clonal-defective cells. The presence of a consistent GPI-defective monocyte compartment is a common feature in PNH patients. To investigate the functional behavior of this population, we analyzed its in vitro differentiation ability toward functional dendritic cells (DCs). Our data indicate that GPI-defective monocytes from PNH patients are unable to undergo full DC differentiation in vitro after granulocyte macrophage-colony stimulating factor and recombinant interleukin (IL)-4 treatment. In this context, the GPI-defective DC population shows mannose receptor expression, high levels of the CD86 molecule, and impaired CD1a up-regulation. The analysis of lipopolysaccharide and CD40-dependent, functional pathways in these DCs revealed a strong decrease in tumor necrosis factor alpha and IL-12 production. Finally, GPI-defective DCs showed a severe impairment in delivering accessory signals for T cell receptor-dependent T cell proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD / immunology
  • Antigens, CD / metabolism
  • Antigens, CD1 / immunology
  • Antigens, CD1 / metabolism
  • B7-2 Antigen
  • CD40 Antigens / immunology
  • Cell Differentiation / genetics
  • Cell Differentiation / immunology*
  • Cell Division / immunology
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Female
  • Glycosylphosphatidylinositols / deficiency*
  • Glycosylphosphatidylinositols / genetics
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Hemoglobinuria, Paroxysmal / blood*
  • Hemoglobinuria, Paroxysmal / genetics
  • Hemoglobinuria, Paroxysmal / immunology*
  • Humans
  • Interleukin-12 / immunology
  • Interleukin-12 / metabolism
  • Interleukin-4 / pharmacology
  • Lectins, C-Type / immunology
  • Lectins, C-Type / metabolism
  • Lipopolysaccharides / immunology
  • Male
  • Mannose Receptor
  • Mannose-Binding Lectins / immunology
  • Mannose-Binding Lectins / metabolism
  • Membrane Glycoproteins / immunology
  • Membrane Glycoproteins / metabolism
  • Monocytes / cytology
  • Monocytes / immunology*
  • Mutation / genetics
  • Receptors, Cell Surface / immunology
  • Receptors, Cell Surface / metabolism
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / immunology

Substances

  • Antigens, CD
  • Antigens, CD1
  • B7-2 Antigen
  • CD1a antigen
  • CD40 Antigens
  • CD86 protein, human
  • Glycosylphosphatidylinositols
  • Lectins, C-Type
  • Lipopolysaccharides
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Membrane Glycoproteins
  • Receptors, Cell Surface
  • Tumor Necrosis Factor-alpha
  • Interleukin-12
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor